Estimating the resources required in the roll-out of universal access to antiretroviral treatment in Zimbabwe

Sexually Transmitted Infections

Volumn 87, Issue 7, 2011, Pages 621-628

  Hallett, Timothy B ^a   Gregson, S ^a,b   Dube, S ^a   Mapfeka, E S ^c   Mugurungi, O ^d   Garnett, G P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b BIOMEDICAL RESEARCH AND TRAINING INSTITUTE   (Zimbabwe)

^c District Medical Office   (Zimbabwe)

^d MINISTRY OF HEALTH AND CHILD CARE   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; DEMOGRAPHY; DISEASE COURSE; FEMALE; HEALTH CARE ACCESS; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NURSE; PATIENT CARE; PATIENT MONITORING; PATIENT REFERRAL; PHYSICIAN; POPULATION GROWTH; PRIORITY JOURNAL; SURVIVAL; ZIMBABWE;

ANTI-HIV AGENTS; HEALTH FACILITIES; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MODELS, THEORETICAL; SURVIVAL ANALYSIS; ZIMBABWE;

EID: 82555192513     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sti.2010.046557     Document Type: Article

References (59)

1. UNAIDS, World Health Organization. Progress on Global Access to HIV Antiretroviral Therapy. An update on "3 by 5", 2005.
2. UNAIDS. AIDS Epidemic Update 2006. http://data.unaids.org/pub/EpiReport/ 2006/2006-EpiUpdate-en.pdf.
3. Lepri AC, Sabin CA, Pezzotti P, et al. Is there a general tendency for CD4 lymphocyte decline to speed up during human immunodeficiency virus infection? Evidence from the Italian Seroconversion Study. J Infect Dis 1997:775-80. 175.
4. Badri M, Maartens G, Mandalia S., et al. Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLoS Med 2006;3:e4.
5. World Health Organization. World Health Statistics. http://www.who.int/ whosis/database/core/core-select.cfm (accessed Sep 2006).
6. Dussault G, Franceschini MC. Not enough there, too many here: understanding geographical imbalances in the distribution of the health workforce. http://info.worldbank.org/etools/docs/library/206832/ Dussault%20Franceschini.pdf.
7. Kurowski C, Wyss K, Abdulla S, et al. Scaling up priority health interventions in Tanzania: the human resources challenge. Health Policy Plan 2007;22:113-27. (Pubitemid 47355784)
8. Salomon JA, Hogan DR, Stover J, et al. Integrating HIV prevention and treatment: from slogans to impact. PLoS Med 2005;2:e16.
9. Stover J, Bertozzi S, Gutierrez JP, et al. The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science 2006;311:1474-6. (Pubitemid 43376704)
10. Stover J, Walker N, Garnett GP, et al. Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet 2002;360:73-7. (Pubitemid 34756499)
11. Badri M, Cleary S, Maartens G, et al. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. Antivir Ther 2006;11:63-72.
12. Hirschhorn LR, Oguda L, Fullem A, et al. Estimating health workforce needs for antiretroviral therapy in resource-limited settings. Hum Resour Health 2006;4:1.
13. Barnighausen T, Bloom DE, Humair S. Universal antiretroviral treatment: the challenge of human resources. Bull World Health Organ 2010;88:951-2.
14. Boerma JT, Stanecki KA, Newell ML, et al. Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Organ 2006;84:145-50. (Pubitemid 43275773)
15. Cheluget B, Baltazar G, Orege P, et al. Evidence for population level declines in adult HIV prevalence in Kenya. Sex Transm Infect 2006;82(Suppl 1):i21-6.
16. Hagopian A, Micek M. Calculating how many health workers are needed at full scale-up in Mozambique. The 2006 HIV/AIDS PEPFAR Implementers' Meeting; Durban, South Africa, 2006.
17. Hallett TB, Gregson S, Dube S, et al. The Impact of Monitoring HIV Patients Prior to Treatment in Resource-Poor Settings: Insights from Mathematical Modelling. PLoS Med 2008;5:e53.
18. Gregson S, Garnett GP, Nyamukapa CA, et al. HIV decline associated with behavior change in eastern Zimbabwe. Science 2006;311:664-6. (Pubitemid 43191311)
19. Laurent C, Bourgeois A, Faye MA, et al. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02-AG strain and patients not infected with CRF02-AG, in Western and West-Central Africa: a four-year prospective multicenter study. J Infect Dis 2002;186:486-92. (Pubitemid 34876257)
20. Kagaayi J, Nakigozi G, Wawer M, et al. WHO staging criteria versus CD4 screening for antiretroviral eligibility in rural Rakai District, Uganda. The 2006 HIV/AIDS PEPFAR Implementers' Meeting; Durban, South Africa, 2006.
21. Kassa E, Rinke de Wit TF, Hailu E, et al. Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers. AIDS 1999;13:381-9. (Pubitemid 29095101)
22. Schneider M, Zwahlen M, Egger M. Natural history and mortality in HIV-positive individuals living in resource-poor settings 2004. http://www.epidem.org.
23. Morgan D, Mahe C, Mayanja B, et al. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002;16:597-603. (Pubitemid 34218855)
24. Adu-Sarkodie Y, Sangare A, d'Almeida OA, et al. Distribution of CD4+ T-lymphocytes levels in patients with clinical symptoms of AIDS in three west African countries. J Clin Virol 1998;11:173-81. (Pubitemid 29047604)
25. Central Statistical Office [Zimbabwe] and Macro International Inc. Zimbabwe demographic and health survey 1999. Calverton, MD: Central Statistical Office and Macro International Inc, 2000.
26. Terceira N, Gregson S, Zaba B, et al. The contribution of HIV to fertility decline in rural Zimbabwe, 1985-2000. Popul Stud (Camb) 2003;57:149-64. (Pubitemid 36922750)
27. Ross A, Van der Paal L, Lubega R, et al. HIV-1 disease progression and fertility: the incidence of recognized pregnancy and pregnancy outcome in Uganda. Aids 2004;18:799-804. (Pubitemid 38535009)
28. WHO, UNAIDS. Guidance On Provider-Initiated HIV Testing And Counselling In Health facilities. In. Geneva, 2007. http://www.who.int/hiv/topics/vct/ PITCguidelines.pdf.
29. Kalamya J, Homsy J, Obonyo J, et al. Routine HIV counselling and testing for Prevention of Mother-to-Child Transmission (PMTCT) of HIV in a rural Ugandan hospital (abstract 101). The 2006 HIV/AIDS PEPFAR Implementers' Meeting; Duran, South Africa, 2006.
30. World Health Organization. Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance: Africa Region. Geneva, 2005.
31. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006;367:817-24.
32. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002;360:119-29. (Pubitemid 34786200)
33. Egger M. Outcomes of Antiretroviral Treatment in Resource Limited and Industrialized Countries. In: 14th Conference on Retroviruses and Opportunistic Infections. Los Angeles, 2007. http://www.retroconference.org/2007/data/files/ webpage-for-CROI.htm.
34. Dube S, Hallett TB, Gregson S, et al. Optimising the population level impact of voluntary counselling and testing in zimbabwe: insights from mathematical models. Atlanta, GC: Department of infectious Disease Epidemiology, Imperial College London; Centers for Disease Control and Prevention (CDC), 2005.
35. Hallett TB, Lopman BA, Gregson S. Why HIV rates have declined in Zimbabwe. Presentation to the UNAIDS Reference Group Steering Committee. Harare, Zimbabwe, 2006.
36. Hallett TB. Mathematical modelling in the response to the HIV/AIDS epidemic in southern Africa. London: University of London, 2007.
37. UNAIDS. Evidence for HIV decline in Zimbabwe: A Comprehensive Review Of The Epidemiological Data 2005. http://www.epidem.org.
38. Mahomva A, Greby S, Dube S, et al. HIV prevalence and trends from data in Zimbabwe, 1997-2004. Sex Transm Infect 2006;82(Suppl 1):i42-7.
39. Population Services International. New hope with new start. Washington, DC, 2006. http://www.psi.org/resources/pubs/New-Start-august-06.pdf (accessed 4 Feb 2011).
40. Population Services International. Marketing HIV counseling and testing 2006. http://www.psi.org/resources/pubs/New-Start-august-06.pdf.
41. World Bank. World Development Report-1991. New York: Oxford University Press, 1991.
42. Anderson RM, May RM, Ng TW, et al. Age-dependent choice of sexual partners and the transmission dynamics of HIV in Sub-Saharan Africa. Philos Trans R Soc Lond B Biol Sci 1992;336:135-55.
43. The Sunday Times (South Africa). Make HIV tests compulsory for South Africans. http://www.sundaytimes.co.za/PrintEdition/Article.aspx?id=481394 (accessed 25 Jun 2007).
44. Autier P, Dore JF, Cattaruzza MS, et al. Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Natl Cancer Inst 1998;90:1873-80.
45. Zimbabwe: DHS, 1999-Final Report (English). http://www.measuredhs.com/ pubs/pub-details.cfm?ID=296&srchTp=advanced (accessed 10 May 2007).
46. Zimbabwe Central Statistics Office. Zimbabwe 2002 population census. Harare: Zimbabwe Central Statistics Office, 2002.
47. Gregson S, Nyamukapa C, Lopman B, et al. Critique of early models of the demographic impact of HIV/AIDS in sub-Saharan Africa based on contemporary empirical data from Zimbabwe. Proc Natl Acad Sci U S A 2007;104:14586-91. (Pubitemid 350003188)
48. Sherr L, Lopman B, Kakowa M, et al. Voluntary counselling and testing: uptake, impact on sexual behaviour, and HIV incidence in a rural Zimbabwean cohort. AIDS 2007;21:851-60. (Pubitemid 46573157)
49. World Health Organization. World Health Statistics 2006. In: http://www.who.int/statistics/en/ (accessed 1 Oct 2006).
50. Fairall LR, Bachmann MO, Louwagie GM, et al. Effectiveness of antiretroviral treatment in a South african program: a cohort study. Arch Intern Med 2008;168:86-93.
51. Diallo K. Data on the migration of health-care workers: sources, uses, and challenges. Bull World Health Organ 2004;82:601-7. (Pubitemid 39108150)
52. Buchan J, Sochalski J. The migration of nurses: trends and policies. Bull World Health Organ 2004;82:587-94. (Pubitemid 39108148)
53. Beck EJ, Vitoria M, Mandalia S, et al. National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines? AIDS 2006;20:1497-502. (Pubitemid 44100210)
54. Montaner JS, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006;368:531-6. (Pubitemid 44142776)
55. Bezemer D, de Wolf F, Boerlijst MC, et al. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 2008;22:1071-7. (Pubitemid 351769746)
56. Dodd PJ, Garnett GP, Hallett TB. Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS 2010;24;729-35.
57. Bakari M, Urassa W, Pallangyo K, et al. The natural course of disease following HIV-1 infection in dar es salaam, Tanzania: a study among hotel workers relating clinical events to CD4 T-lymphocyte counts. Scand J Infect Dis 2004;36:466-73. (Pubitemid 39089198)
58. Morgan D, Ross A, Mayanja B, et al. Early manifestations (pre-AIDS) of HIV-1 infection in Uganda. AIDS 1998;12:591-6. (Pubitemid 28162097)
59. Morgan D, Mahe C, Mayanja B, et al. Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. BMJ 2002;324:193-6. (Pubitemid 34107081)